NCT06906601 Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
| NCT ID | NCT06906601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Leon Berard |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 772 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2027-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 772 participants in total. It began in 2025-04-15 with a primary completion date of 2027-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
MAGNETO is a French medico-economic study on preoperative localization in breast cancer surgery. The main objective is to conduct a cost-consequence analysis comparing magnetic clip localization with the use of metallic wires for the preoperative identification of non-palpable breast lesions. The choice of localization method is left to the physician's and center's discretion. The study is non-interventional (with only questionnaires and data collection), prospective, and multicenter, with patient follow-up lasting up to six months after breast surgery.
Eligibility Criteria
Inclusion Criteria: * I1. Female aged ≥ 18 years; * I2. Patient presenting with a unifocal and unilateral lesion of invasive carcinoma or in situ; * I3. Indication for first breast-conserving treatment with the need for preoperative localization of the lesion, regardless of the associated lymph node procedure; * I4. Patient affiliated with a health insurance system; * I5. Non-opposition to the study. Exclusion Criteria: * E.1. Psychological, family, or sociological condition that may potentially compromise adherence to the treatment protocol and follow-up; * E.2. Bilateral surgery required; * E.3. Patient with metastatic breast cancer; * E.4. Multifocal or benign lesions; * E.5. Pregnant or breastfeeding patient; * E.6. Need for neoadjuvant treatment; * E.8. Patient under guardianship, curatorship, or deprived of liberty.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06906601 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06906601 currently recruiting?
Yes, NCT06906601 is actively recruiting participants. Contact the research team at severine.metzger@lyon.unicancer.fr for enrollment information.
Where is the NCT06906601 trial being conducted?
This trial is being conducted at Lyon, France, Lyon, France, Nancy, France, Pontoise, France and 3 additional locations.
Who is sponsoring the NCT06906601 clinical trial?
NCT06906601 is sponsored by Centre Leon Berard. The trial plans to enroll 772 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.